Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Marcaine with Epinephrine

Generic name: Bupivacaine hydrochloride and epinephrine bitartrate

FDA application holder: Hospira

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Marcaine with Epinephrine?
Marcaine with Epinephrine is a brand name of Bupivacaine hydrochloride and epinephrine bitartrate, a prescription medicine. The FDA NDC Directory lists 11 Marcaine with Epinephrine products in 4 strengths and forms.
Who makes Marcaine with Epinephrine?
Hospira holds the FDA application for Marcaine with Epinephrine (NDA016964, approved October 3, 1972). 1 other company (repackagers or distributors) also list Marcaine with Epinephrine products.
Is there a generic or store brand of Marcaine with Epinephrine?
Other products of Bupivacaine hydrochloride and epinephrine bitartrate are listed with the FDA, but none in exactly the same strength and form as a Marcaine with Epinephrine product.
Has Marcaine with Epinephrine been recalled?
No recall linked to Marcaine with Epinephrine products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Marcaine with Epinephrine is

Each Marcaine with Epinephrine product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Bupivacaine hydrochloride and epinephrine bitartrate · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
bupivacaine hydrochloride 2.5 mg/mL · epinephrine bitartrate 0.0091 mg/mL
injection, solution (infiltration, perineural)
Marcaine with Epinephrine None listed DailyMed
bupivacaine hydrochloride 2.5 mg/mL · epinephrine bitartrate 0.0091 mg/mL
injection, solution (epidural, infiltration, intracaudal, perineural)
Marcaine with Epinephrine None listed DailyMed
bupivacaine hydrochloride 5 mg/mL · epinephrine bitartrate 0.0091 mg/mL
injection, solution (perineural)
Marcaine with Epinephrine None listed DailyMed
bupivacaine hydrochloride 5 mg/mL · epinephrine bitartrate 0.0091 mg/mL
injection, solution (epidural, intracaudal, perineural)
Marcaine with Epinephrine None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Bupivacaine hydrochloride and epinephrine bitartrate →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Marcaine with Epinephrine products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA016964HospiraOctober 3, 197211

Companies that list Marcaine with Epinephrine

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Marcaine with Epinephrine products.

Recalls

No recall linked to Marcaine with Epinephrine products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers